Chase AIPricingFAQs
Display currency
Loading news…

Osseon Therapeutics

ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).
Santa Rosa, California, United States Founded 2007 11-50 employees For Profit

Osseon Therapeutics develops medical devices for minimally-invasive treatments of degenerative bone and joint diseases.

Total Funding
Available in Pro
Last Funding
Available in Pro
Acquisitions
0
Monthly Visits
Available in Pro
Contacts
5
Patents
5

Company Details

Funding & Financials

Pro
Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

IPO & Stock

IPO status
Private

Web Traffic

Pro
Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
1
Active products
3
Patents granted
5
Trademarks
0
Top patent class
Medical Or Veterinary Science; Hygiene
IT spend
$9M

Company Info

Founded
2007
Employees
11-50
Operating status
Closed
Company type
For Profit
Org types
company
Founders
1
News articles
6
HQ
Santa Rosa, California, United States
Region
San Francisco Bay Area, West Coast, Western US
Closed
Sep 5, 2014

Signals & Scores

Heat score
Low
Trend (7d)
1.9
Trend (30d)
6.4
Trend (90d)
6.6

Key People at Osseon Therapeutics

Area Director of Sales
Director of R&D
Co-Founder and VP of Research and Development
5
professional contacts at Osseon Therapeutics
Contact execs at Osseon Therapeutics

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions

Recent News related to Osseon Therapeutics

Loading news…

FAQs about Osseon Therapeutics

People who checked this page also checked these

Browse the full Acquirezy directory.
Osseon Therapeutics - Company Profile, Full Acquisitions List, Funding and Investments